Cargando…
Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review
Chronic liver disease (CLD) is an under-recognized epidemic that continues to increase in prevalence and is a major health concern. Silymarin, the active compound of Silybum marianum (Milk thistle), has historically been used in CLD. A significant barrier to silymarin use is its poor bioavailability...
Autores principales: | Tighe, Sean P., Akhtar, Daud, Iqbal, Umair, Ahmed, Aijaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782115/ https://www.ncbi.nlm.nih.gov/pubmed/33447529 http://dx.doi.org/10.14218/JCTH.2020.00012 |
Ejemplares similares
-
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
por: Iqbal, Umair, et al.
Publicado: (2019) -
Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019) -
Kratom-Induced Cholestatic Liver Injury and Its Conservative Management
por: Fernandes, Christopher T., et al.
Publicado: (2019) -
Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis
por: de Avelar, Camila Ribeiro, et al.
Publicado: (2017) -
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review
por: Aghemo, Alessio, et al.
Publicado: (2022)